| |
| |
|
| Insider
Information: |
Vivo Opportunity Fund, L.p. |
| Relationship: |
10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
711,044 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$10,058,803 |
|
|
| Total
Shares |
711,044 |
|
|
| Total
Value |
$10,058,803 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
7
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-7.0
|
| Percentage
Gain/Loss : |
 -56.8%
|
-258.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2020-03-09 |
168,165 |
Premium* |
|
|
Alx Oncology Holdings Inc |
ALXO |
10% Owner |
2020-07-21 |
0 |
2020-07-21 |
185,526 |
Premium* |
|
|
Terns Pharmaceuticals, Inc. |
TERN |
10% Owner |
2021-02-09 |
0 |
2021-02-09 |
357,353 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TERN |
Terns Pharmaceuticals, In... |
10% Owner |
– – • |
2021-02-09 |
4 |
B |
$17.00 |
$8,075,000 |
I/I |
475,000 |
357,353 |
1.5 |
% |
|
| TERN |
Terns Pharmaceuticals, In... |
10% Owner |
– – • |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,200,133 |
266,948 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
10% Owner |
– – • |
2020-07-21 |
4 |
B |
$19.00 |
$18,525,000 |
I/I |
975,000 |
185,526 |
1.5 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,245,048 |
4,034,522 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-03-09 |
4 |
S |
$19.50 |
$10,296 |
I/I |
(528) |
168,165 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-02-10 |
4 |
S |
$21.40 |
$161,677 |
I/I |
(7,555) |
168,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-02-07 |
4 |
S |
$22.00 |
$129,910 |
I/I |
(5,905) |
174,202 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-02-04 |
4 |
S |
$22.80 |
$306,888 |
I/I |
(13,460) |
178,816 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-01-31 |
4 |
S |
$21.70 |
$117,180 |
I/I |
(5,400) |
189,335 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-01-30 |
4 |
S |
$22.10 |
$167,960 |
I/I |
(7,600) |
193,555 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2020-01-29 |
4 |
S |
$22.20 |
$309,024 |
I/I |
(13,920) |
199,495 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2019-03-20 |
4 |
S |
$22.25 |
$9,278,250 |
I/I |
(417,000) |
210,373 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
B |
$17.00 |
$6,575,421 |
I/I |
353,180 |
294,357 |
1.5 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
3,384,278 |
410,625 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
